BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
NCT 06120283 Brief Summary This is a dose escalation and dose expansion…
Read more arrow_forwardNCT 06120283 Brief Summary This is a dose escalation and dose expansion…
Read more arrow_forwardNCT 04918810 Brief Summary The purpose of this study is to see…
Read more arrow_forwardNCT 03522064 Brief Summary The purpose of this study is to determine…
Read more arrow_forwardNCT 05440786 Intervention / Treatment Drug: Abemaciclib Drug: Irinotecan Drug: Temozolomide Inclusion Criteria Diagnosis of…
Read more arrow_forwardNCT 04862663 Brief Summary A Phase Ib/III Open-label, Randomised Study of Capivasertib…
Read more arrow_forwardNCT 05666700 Brief Summary This clinical trial will investigate the in vivo…
Read more arrow_forwardNCT 05796089 Brief Summary This is a prospective, multi-centre, single arm,…
Read more arrow_forwardNCT 05352672 Brief Summary This study is researching an experimental drug called…
Read more arrow_forwardNCT 05523947 Brief Summary This first-in-human study will be counducted to evaluate…
Read more arrow_forwardACTRN 12623000640606 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forward